Carillon Tower Advisers’s CVS Health CVS Stock Holding History

Carillon Tower Advisers’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$3.71M	Sell	54,300 -2,100	-4%	-$137K	0.02%	431
2020 Q3	$3.29M	Sell	56,400 -4,400	-7%	-$274K	0.04%	374
2020 Q2	$3.95M	Buy	60,800 +26,200	+76%	+$1.65M	0.03%	387
2020 Q1	$2.05M	Buy	+34,600	New	+$2.31M	0.02%	401
2019 Q1	–	Sell	-60,939	Closed	-$3.99M	–	465
2018 Q4	$3.99M	Buy	+60,939	New	+$4.55M	0.03%	377
2018 Q3	–	Sell	-26,800	Closed	-$1.72M	–	437
2018 Q2	$1.72M	Buy	+26,800	New	+$1.77M	0.01%	447

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Carillon Tower Advisers's CVS Position: Q4 2020 in Review

Carillon Tower Advisers reduced its CVS Health (CVS) stake by 3.7% in Q4 2020, selling an estimated $137K and leaving 54,300 shares worth $3.71M. The position accounts for 0.02% of the portfolio, ranked #431.

Carillon Tower Advisers first reported a position in CVS in Q2 2018 and has held it in 6 quarters since. The position peaked at $3.99M in Q4 2018. 1,974 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

Carillon Tower Advisers held 54,300 shares of CVS Health worth $3.71M as of Q4 2020.
Carillon Tower Advisers sold 2,100 CVS Health shares in Q4 2020, an estimated $137K.
CVS Health made up 0.02% of Carillon Tower Advisers's portfolio in Q4 2020, its #431 holding.
Carillon Tower Advisers first reported a position in CVS Health in Q2 2018 and has held it in 6 quarters since.
Carillon Tower Advisers's CVS Health position peaked at $3.99M in Q4 2018.
1,974 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.